ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T-Cell Function and Anti-PD-1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated Metabolomics, Transcriptomics and T-Cell-Incorporated Tumor Organoid Studies.

Tingting Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.